Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients


News out of the local life sciences industry this week includes firms making progress on experimental treatments for brain cancer and depression, a discovery that could help HIV patients, and a potentially big deal in Big Pharma.

Previous Peninsula drug maker Cytokinetics ends late-stage study in ALS
Next Iron City Grill closing, private events to continue